EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

A prospective trial comparing programmable targeted long-read sequencing and short-read genome sequencing for genetic diagnosis of cerebellar ataxia

Haloom Rafehi, Liam G Fearnley, Justin Read, Penny Snell, Kayli C Davies, Liam Scott, Greta Gillies, Genevieve C Thompson, Tess A Field, Aleena Eldo, Simon Bodek, Ernest Butler und 30 weitere

Genome Research · 2025

DOI: 10.1101/gr.279634.124 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Genome Research, 2025. Verfasst von Haloom Rafehi und 41 weiteren Autor:innen. Beteiligte Einrichtung: Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia. Hauptthemen laut MEDLINE: Cerebellar Ataxia, High-Throughput Nucleotide Sequencing, Genetic Testing. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Australian Government National Health and Medical Research Council, NHMRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cerebellar ataxias (CAs) are a heterogeneous group of disorders characterized by progressive incoordination. Seventeen repeat expansion (RE) loci have been identified as the primary genetic cause and account for >80% of genetic diagnoses. Despite this, diagnostic testing is limited and inefficient, often utilizing single gene assays. This study evaluates the effectiveness of long- and short-read sequencing as diagnostic tools for CA. We recruited 110 individuals (48 females, 62 males) with a clinical diagnosis of CA. Short-read genome sequencing (SR-GS) was performed to identify pathogenic RE and also non-RE variants in 356 genes associated with CA. Independently, long-read sequencing with adaptive sampling (LR-AS) was performed to identify pathogenic RE. SR-GS provided a genetic diagnosis for 38% of the cohort (40/110) including seven non-RE pathogenic variants. RE causes disease in 33 individuals, with the most common condition being SCA27B ( n = 24). In comparison, LR-AS identified pathogenic RE in 29 individuals. RE identification for the two methods was concordant apart from four SCA27B cases not detected by LR-AS due to low read depth. For both technologies manual review of the RE alignment enhances diagnostic outcomes. Orthogonal testing for SCA27B revealed a 15% and 0% false positive rate for SR-GS and LR-AS, respectively. In conclusion, both technologies are powerful screening tools for CA. SR-GS is a mature technology currently used by diagnostic providers, requiring only minor changes in bioinformatic workflows to enable CA diagnostics. LR-AS offers considerable advantages in the context of RE detection and characterization but requires optimization before clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebellar AtaxiaHigh-Throughput Nucleotide SequencingGenetic TestingHumansMaleFemaleMiddle AgedAdultProspective StudiesDNA Repeat ExpansionSequence Analysis, DNAAgedWhole Genome SequencingAdolescentGenome, Human

Autor:innen und Institutionen

  • Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.
  • Department of Medical Biology, University of Melbourne, Parkville, Victoria 3052, Australia.
  • Bruce Lefroy Centre, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria 3052, Australia.
  • Department of Neuroscience, Central Clinical School, Monash University, The Alfred Centre, Melbourne, Victoria 3004, Australia.
  • Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Parkville, Victoria 3052, Australia.
  • Austin Health, Heidelberg, Victoria 3084, Australia.

ORCID-Profile: Melanie Bahlo, Paul J Lockhart

Förderung

  • Australian Government National Health and Medical Research Council
  • NHMRC

Zitieren

APA

Rafehi, H., Fearnley, L. G., Read, J., Snell, P., Davies, K. C., Scott, L., Gillies, G., Thompson, G. C., Field, T. A., Eldo, A., Bodek, S., Butler, E., Chen, L., Drago, J., Goel, H., Hackett, A., Halmagyi, G. M., Hannaford, A., Kotschet, K., …, & Lockhart, P. J. (2025). A prospective trial comparing programmable targeted long-read sequencing and short-read genome sequencing for genetic diagnosis of cerebellar ataxia. Genome Research. https://doi.org/10.1101/gr.279634.124

Vancouver

Rafehi H, Fearnley LG, Read J, Snell P, Davies KC, Scott L, et al. A prospective trial comparing programmable targeted long-read sequencing and short-read genome sequencing for genetic diagnosis of cerebellar ataxia. Genome Research. 2025. doi:10.1101/gr.279634.124

BibTeX
@article{Rafehi2025,
  author = {Rafehi, Haloom and Fearnley, Liam G and Read, Justin and Snell, Penny and Davies, Kayli C and Scott, Liam and Gillies, Greta and Thompson, Genevieve C and Field, Tess A and Eldo, Aleena and Bodek, Simon and Butler, Ernest and Chen, Luke and Drago, John and Goel, Himanshu and Hackett, Anna and Halmagyi, G Michael and Hannaford, Andrew and Kotschet, Katya and Kumar, Kishore R and Kumble, Smitha and Lee-Archer, Matthew and Malhotra, Abhishek and Paine, Mark and Poon, Michael and Pope, Kate and Reardon, Katrina and Ring, Steven and Ronan, Anne and Silsby, Matthew and Smyth, Renee and Stutterd, Chloe and Wallis, Mathew and Waterston, John and Wellings, Thomas and West, Kirsty and Wools, Christine and Wu, Kathy H C and Szmulewicz, David J and Delatycki, Martin B and Bahlo, Melanie and Lockhart, Paul J},
  title = {A prospective trial comparing programmable targeted long-read sequencing and short-read genome sequencing for genetic diagnosis of cerebellar ataxia},
  journal = {Genome Research},
  year = {2025},
  doi = {10.1101/gr.279634.124}
}
Kostenlos starten →